Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

KELLY W HUBBARD

Allopathic & Osteopathic Physicians Dermatology

NPI
1871542308
CMS profile
1043097
Location
NORTH LOGAN, UT

General Payments · PY2018–2024

$3,910.74

  • Reported across 205 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$742.12

33 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $742.12 33

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
UCB, Inc. $210.56 4
NOVARTIS PHARMACEUTICALS CORPORATION $174.08 11
ABBVIE INC. $79.41 4
Lilly USA, LLC $58.28 3
Janssen Biotech, Inc. $45.04 2
MIMEDX Group, Inc. $44.52 2
Dermavant Sciences, Inc. $42.88 3
Amgen Inc. $25.30 1
REVANCE THERAPEUTICS, INC. $24.64 1
LEO Pharma Inc. $19.08 1
Galderma Laboratories, L.P. $18.33 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $482.64 20
PY2019 $566.96 31
PY2020 $445.13 25
PY2021 $420.15 25
PY2022 $470.08 30
PY2023 $783.66 41
PY2024 $742.12 33

Payment records · PY2024 (33)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $18.62 01/24/2024 Food and Beverage Undisputed 01/23/2026 1103949020 CMS
ABBVIE INC. $15.57 08/08/2024 Food and Beverage Undisputed 01/23/2026 1103949022 CMS
ABBVIE INC. $22.03 09/06/2024 Food and Beverage Undisputed 01/23/2026 1103949024 CMS
ABBVIE INC. $23.19 12/04/2024 Food and Beverage Undisputed 01/23/2026 1103949026 CMS
Amgen Inc. $25.30 10/17/2024 Food and Beverage Undisputed 01/23/2026 1117281977 CMS
Dermavant Sciences, Inc. $14.55 03/18/2024 Food and Beverage Undisputed 01/23/2026 1127881293 CMS
Dermavant Sciences, Inc. $13.57 08/27/2024 Food and Beverage Undisputed 01/23/2026 1127881297 CMS
Dermavant Sciences, Inc. $14.76 12/12/2024 Food and Beverage Undisputed 01/23/2026 1127881301 CMS
Galderma Laboratories, L.P. $18.33 08/30/2024 Food and Beverage Undisputed 01/23/2026 1145305327 CMS
Janssen Biotech, Inc. $22.26 04/17/2024 Food and Beverage Undisputed 01/23/2026 1078788326 CMS
Janssen Biotech, Inc. $22.78 06/26/2024 Food and Beverage Undisputed 01/23/2026 1078788313 CMS
LEO Pharma Inc. $19.08 03/06/2024 Food and Beverage Undisputed 01/23/2026 1152635283 CMS
Lilly USA, LLC $20.66 08/06/2024 Food and Beverage Undisputed 01/23/2026 1135105443 CMS
Lilly USA, LLC $14.21 10/21/2024 Food and Beverage Undisputed 01/23/2026 1135096994 CMS
Lilly USA, LLC $23.41 11/07/2024 Food and Beverage Undisputed 01/23/2026 1135103397 CMS
MIMEDX Group, Inc. $17.81 03/25/2024 Food and Beverage Undisputed 01/23/2026 1140261301 CMS
MIMEDX Group, Inc. $26.71 12/30/2024 Food and Beverage Undisputed 01/23/2026 1140261303 CMS
Novartis Pharmaceuticals Corporation $22.98 01/03/2024 Food and Beverage Undisputed 01/23/2026 1086840057 CMS
Novartis Pharmaceuticals Corporation $25.58 02/05/2024 Food and Beverage Undisputed 01/23/2026 1086840063 CMS
Novartis Pharmaceuticals Corporation $13.63 03/28/2024 Food and Beverage Undisputed 01/23/2026 1086840069 CMS
Novartis Pharmaceuticals Corporation $15.58 04/29/2024 Food and Beverage Undisputed 01/23/2026 1086840075 CMS
Novartis Pharmaceuticals Corporation $3.06 04/29/2024 Food and Beverage Undisputed 01/23/2026 1086840077 CMS
Novartis Pharmaceuticals Corporation $19.72 07/11/2024 Food and Beverage Undisputed 01/23/2026 1086840083 CMS
Novartis Pharmaceuticals Corporation $22.27 08/15/2024 Food and Beverage Undisputed 01/23/2026 1086840087 CMS
Novartis Pharmaceuticals Corporation $2.41 08/15/2024 Food and Beverage Undisputed 01/23/2026 1086840089 CMS
Novartis Pharmaceuticals Corporation $21.64 10/10/2024 Food and Beverage Undisputed 01/23/2026 1086840097 CMS
Novartis Pharmaceuticals Corporation $2.74 10/28/2024 Food and Beverage Undisputed 01/23/2026 1086840109 CMS
Novartis Pharmaceuticals Corporation $24.47 10/28/2024 Food and Beverage Undisputed 01/23/2026 1086840111 CMS
REVANCE THERAPEUTICS, INC. $24.64 08/26/2024 Food and Beverage Undisputed 01/23/2026 1147920458 CMS
UCB, Inc. $20.48 01/08/2024 Food and Beverage Undisputed 01/23/2026 1143067143 CMS
UCB, Inc. $125.45 01/12/2024 Food and Beverage Undisputed 01/23/2026 1143067145 CMS
UCB, Inc. $33.66 04/23/2024 Food and Beverage Undisputed 01/23/2026 1143067147 CMS
UCB, Inc. $30.97 11/18/2024 Food and Beverage Undisputed 01/23/2026 1143067149 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.